Laureate Education heads into the back half of August with an unusual split: short sellers are abandoning the stock at a rapid clip while the Street's most vocal institutional supporter just downgraded it.
The most notable development this week came from JP Morgan. On August 3, the firm's analyst downgraded LAUR to Neutral from Overweight — keeping the $41 price target unchanged but pulling back its positive conviction just two weeks after the company's latest earnings print. That move matters because JP Morgan initiated coverage only in December 2025 and had been the stock's most active institutional advocate, raising its target twice in three months before reversing course. The rest of the rated universe remains constructive: UBS holds a Buy with a $39 target and BMO Capital maintains Outperform at $43. With the stock at $37.62, the mean target implies around 9% upside from current levels — respectable, but the direction of travel on the Street has shifted from building enthusiasm to selective caution.
The short data tells a sharply different story from the analyst action. Bears have been covering hard. Short interest has fallen 26% in one week and 43.5% over the past month, dropping to just 1.75% of the free float — a level low enough that the short angle carries almost no weight as a standalone catalyst. Borrowing costs have followed, easing to 0.44% with availability extremely loose at nearly 1,500% of short interest, meaning there are roughly fifteen times as many shares available to borrow as are currently borrowed. The ORTEX short score has drifted lower through August, now at 33, consistent with a steadily unwinding short base rather than any squeeze dynamic. Options positioning reinforces the calm: the put/call ratio of 0.11 is running slightly below its 20-day average of 0.12, with a z-score just modestly negative — no sign of hedging pressure building in either direction.
The bull-bear debate on LAUR ultimately centres on whether enrollment momentum in Latin America translates into margin expansion. Management raised guidance this year on 6% new-student growth in Peru and 8% in Mexico, and the company scores in the 67th percentile on EPS surprise, suggesting it has historically delivered relative to expectations. The bear case is harder to dismiss, though: the adjusted EBITDA margin ran at just 2.3% in the most recent quarter, forward EPS growth ranks in only the 16th percentile, and revenue per enrollment has been trending lower. The EV/EBITDA multiple of 8.8x is undemanding, and the EV/EBIT factor score ranks in the 71st percentile — value investors have reason to look. But a price-to-book of 4.0x offers less margin of safety if the margin story disappoints again. The ORTEX stock score of 78 reflects strong quality and momentum metrics, though a sharply negative forward EPS growth estimate tempers that read.
Among the peer group, the week has been broadly tough for education names. PRDO fell 5.4% and LOPE dropped 5.5%. APEI slid 11.7% and LINC sold off nearly 27%. Against that backdrop, LAUR's 1.9% weekly decline looks relatively contained — the stock is holding up better than most of its correlated peers, which may partly reflect the ongoing short-covering flow providing a modest technical bid.
The next scheduled earnings release is October 29. Between now and then, the key tension is whether the JP Morgan downgrade proves prescient — margin pressure catching up with the enrollment growth story — or whether the remaining bulls at UBS and BMO are right that the guidance raise signals something more durable.
See the live data behind this article on ORTEX.
Open LAUR on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
